Auto logout in seconds.
Continue Logout
Risant Health has agreed to acquire Integris Health, making it the third health system to join the value-based care (VBC) network, in today's bite-sized hospital and health industry news from California, Oklahoma, and Pennsylvania.
- California: Oura is collaborating with UC San Diego Health on a new clinical trial called SMART-BMI that will study the link between smart ring data and obesity treatment outcomes. The multi-year study will examine whether continuous data from the Oura Ring, including sleep, heart rate, and activity, will impact outcomes for patients taking GLP-1 medications or undergoing bariatric surgery. Data from the Oura Ring will record changes between care visits, and researchers will examine any potential association with outcomes, such as weight loss, HbA1c, and treatment persistence. "UC San Diego Health is precisely where innovative technology and subject matter experts come together to advance human health," said Alexander Khalessi, neurosurgeon and chief innovation officer at UC San Diego Health. "We are proud of the thought leadership of Dr. [Jeff] Reeves and Oura's engagement to take on these important clinical questions for our patients." According to Fierce Healthcare, the study is part of Oura's broader efforts in clinical research, which is being coordinated through its recently established Office of Regulatory and Clinical Affairs. (Landi, Fierce Healthcare, 10/29)
- Oklahoma: Risant Health has agreed to acquire Integris Health, making it the third health system to join the value-based care network. Kaiser Permanente originally formed Risant in 2024 as a separate nonprofit entity to acquire health systems and create a national VBC network. So far, Risant has acquired two health systems, Geisinger Health and Cone Health. Integris will be the third health system acquired by Risant, with the proposed deal expected to close in early 2027. After closing, Integris will retain its branding, medical staff, and leadership team. Currently, Integris is the largest nonprofit health system in Oklahoma and operates 20 acute and specialty hospitals, physician clinics, and urgent care centers. "Together, Risant Health and its organizations are moving healthcare from siloed, episodic care to a value-based care approach with an increased focus on evidence-based care that achieves healthier outcomes for more people," said Kaiser Permanente Chair and CEO Greg Adams. "Integris Health's expertise in complex clinical services, combined with its experiences in value-based care, offers an opportunity to continue improving health and affordability for the people of Oklahoma." (Hudson, Modern Healthcare, 10/21; Muoio, Fierce Healthcare, 10/21)
- Pennsylvania: Penn Medicine has established a new $35 million brain tumor center aimed at translating the system's cell therapy research into treatment options. The Troiano Brain Tumor Center will focus on early-phase clinical trials and coordinated care, building on CAR-T cell therapy and the mRNA platform behind COVID-19 vaccines that were pioneered at Penn. The center will house efforts on brain tumors in one place, uniting neurosurgery, hematology-oncology, neuroradiology, and more. Nduka Amankulor serves as the center's executive director while Dolores Hambardzumyan has been named its scientific director and Stephen Bagley has been named its clinical director. "The Troiano Brain Tumor Center brings together an exceptional team to tackle one of the most challenging areas in cancer care," said Daniel Yoshor, the Charles Harrison Frazier Professor and chair of the neurosurgery department at Penn. "John and Rosanna Troiano's generous support comes at a pivotal moment at which our team is making groundbreaking discoveries in this field. Their partnership will help advance this work to the benefit of patients around the world." (Twenter, Becker's Hospital Review, 10/29; Penn Medicine news release, 10/29)
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board
Never miss out on the latest innovative health care content tailored to you.
Benefits Include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
This is for members only. Learn more.
Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board
Never miss out on the latest innovative health care content tailored to you.
Benefits Include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
